A Study of the Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease Psychosis

NCT02035553 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

181

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease Psychosis

Interventions

DRUG: Pimavanserin tartrate
DRUG: Placebo

Sponsor

ACADIA Pharmaceuticals Inc.